Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma.

Margolin K, Atkins M, Sparano J, Sosman J, Weiss G, Lotze M, Doroshow J, Mier J, O'Boyle K, Fisher R, Campbell E, Rubin J, Federighi D, Bursten S
Clin Cancer Res. 1997 3 (4): 565-72

PMID: 9815721

MeSH Terms (18)

Adult Aged Anti-Inflammatory Agents, Non-Steroidal Creatinine Dose-Response Relationship, Drug Drug Administration Schedule Humans Injections, Intravenous Interleukin-2 Kidney Neoplasms Melanoma Middle Aged Monte Carlo Method Nausea Pentoxifylline Placebos Prospective Studies Recombinant Proteins

Connections (1)

This publication is referenced by other Labnodes entities: